Bausch + Lomb Corporation (BLCO)
NYSE
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
17.1152 wk Range
14.44Overview - BLCO - Bausch + Lomb Corporation
Key Statistics
Valuation
Enterprise Value
10.70B
P/E (Trailing)
-16.15
P/E (Forward)
14.80
PEG Ratio
0.20
Price / Sales (TTM)
1.10
Price / Book
0.91
EV / EBITDA
13.12
Profitability
Gross Margin
62.19%
Profit Margin
-3.21%
Operating Margin
7.74%
Return on Assets
1.82%
Return on Equity
-2.51%
Ownership
Shares Outstanding
357.05M
Float
46.06M
Short % of Shares Outstanding
6.48%
Held by Insiders
87.28%
Held by Institutions
11.14%
Price stats
Beta
0.56
50-Day Avg
17.12
200-Day Avg
16.62
Dividends
Payout Ratio
0.00%
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BLCO - Bausch + Lomb Corporation
Peers - BLCO - Bausch + Lomb Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
- BLCONYSEBausch + Lomb Corporation5.88BMarket Cap+4.49%52-week change-16.16P/E (Trailing)-3.21%Profit Margin
- BDXNYSEBecton, Dickinson and Company51.95BMarket Cap+22.09%52-week change44.36P/E (Trailing)4.19%Profit Margin
- RMDNYSEResMed Inc.35.56BMarket Cap-2.51%52-week change24.24P/E (Trailing)26.94%Profit Margin
- ELNYSEThe Estée Lauder Companies Inc. Class A Common Stock35.52BMarket Cap+5.42%52-week change196.10P/E (Trailing)1.20%Profit Margin
- ALCNYSEAlcon Inc.33.92BMarket Cap-8.45%52-week change53.16P/E (Trailing)5.92%Profit Margin
- WSTNYSEWest Pharmaceutical Services Inc.27.02BMarket Cap+28.41%52-week change49.36P/E (Trailing)16.98%Profit Margin
- SOLVNYSESolventum Corporation14.85BMarket Cap+17.99%52-week change10.63P/E (Trailing)17.25%Profit Margin
Profile Summary - BLCO - Bausch + Lomb Corporation
About
Bausch + Lomb Corporation is a global eye health company that develops, manufactures, and markets products for vision care, surgical care, and ophthalmic pharmaceuticals. Bausch + Lomb offers contact lenses, lens care solutions, eye drops, vitamins and supplements, and prescription therapies for a range of eye…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
